Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析

◆英語タイトル:Jiangsu Hengrui Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1683
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Jiangsu Hengrui Medicine Co Ltd (600276) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Jiangsu Hengrui Medicine Co Ltd (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of novel pharmaceutical products. Its product portfolio includes antineoplastic products, anti-tumor drugs, surgical drugs and contrast agents. The company offers products in therapeutic areas of central nervous system (CNS), musculoskeletal, metabolic, hematologic, infection, respiratory, cardiovascular, dermatology, gastrointestinal and oncology. Jiangsu Hengrui has manufacturing and R&D facilities in China, the US and Japan. The company offers products through its sales and distribution network across China. Jiangsu Hengrui is headquartered in Lianyungang, Jiangsu Province, China.

Jiangsu Hengrui Medicine Co Ltd Key Recent Developments

Feb 18,2020 Hengrui Medicine donated another 3 million yuan worth of innovative medicine to aid Hubei
Jan 25,2020 Hengrui Pharmaceutical donated RMB 5 million in special donations and medical protection materials
Jun 18,2019 Mycovia and Hengrui Medicine to commercialise VT-1161 for RVVC

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Jiangsu Hengrui Medicine Co Ltd – Key Facts
Jiangsu Hengrui Medicine Co Ltd – Key Employees
Jiangsu Hengrui Medicine Co Ltd – Key Employee Biographies
Jiangsu Hengrui Medicine Co Ltd – Major Products and Services
Jiangsu Hengrui Medicine Co Ltd – History
Jiangsu Hengrui Medicine Co Ltd – Company Statement
Jiangsu Hengrui Medicine Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Jiangsu Hengrui Medicine Co Ltd – Business Description
R&D Overview
Jiangsu Hengrui Medicine Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Jiangsu Hengrui Medicine Co Ltd – Strengths
Jiangsu Hengrui Medicine Co Ltd – Weaknesses
Jiangsu Hengrui Medicine Co Ltd – Opportunities
Jiangsu Hengrui Medicine Co Ltd – Threats
Jiangsu Hengrui Medicine Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Jiangsu Hengrui Medicine Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 18, 2020: Hengrui Medicine donated another 3 million yuan worth of innovative medicine to aid Hubei
Jan 25, 2020: Hengrui Pharmaceutical donated RMB 5 million in special donations and medical protection materials
Jun 18, 2019: Mycovia and Hengrui Medicine to commercialise VT-1161 for RVVC
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Jiangsu Hengrui Medicine Co Ltd, Key Facts
Jiangsu Hengrui Medicine Co Ltd, Key Employees
Jiangsu Hengrui Medicine Co Ltd, Key Employee Biographies
Jiangsu Hengrui Medicine Co Ltd, Major Products and Services
Jiangsu Hengrui Medicine Co Ltd, History
Jiangsu Hengrui Medicine Co Ltd, Subsidiaries
Jiangsu Hengrui Medicine Co Ltd, Joint Venture
Jiangsu Hengrui Medicine Co Ltd, Key Competitors
Jiangsu Hengrui Medicine Co Ltd, Ratios based on current share price
Jiangsu Hengrui Medicine Co Ltd, Annual Ratios
Jiangsu Hengrui Medicine Co Ltd, Annual Ratios (Cont...1)
Jiangsu Hengrui Medicine Co Ltd, Annual Ratios (Cont...2)
Jiangsu Hengrui Medicine Co Ltd, Interim Ratios
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Jiangsu Hengrui Medicine Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Jiangsu Hengrui Medicine Co Ltd, Performance Chart (2015 - 2019)
Jiangsu Hengrui Medicine Co Ltd, Ratio Charts
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ensign Bickford Aerospace & Defense Company:企業の戦略・SWOT・財務情報
    Ensign Bickford Aerospace & Defense Company - Strategy, SWOT and Corporate Finance Report Summary Ensign Bickford Aerospace & Defense Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Swissgrid AG:電力:M&Aディール及び事業提携情報
    Summary Swissgrid AG (Swissgrid) is a national grid company that operates, maintains, modernizes and expands the electricity transmission system in Switzerland. It conducts the import and export of electricity to maintain the utilization levels. The company also provides additional services, such as …
  • Carso Infraestructura y Construccion SA De CV:企業の戦略・SWOT・財務情報
    Carso Infraestructura y Construccion SA De CV - Strategy, SWOT and Corporate Finance Report Summary Carso Infraestructura y Construccion SA De CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Breas Medical AB:医療機器:M&Aディール及び事業提携情報
    Summary Breas Medical AB (Breas), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co Ltd, is a medical device company that manufactures and markets medical devices for anesthesia and respiratory markets. The company provides isleep and vivo products. It provides products such as isleep, vivo 3 …
  • Shermco Industries Inc:企業の戦略的SWOT分析
    Shermco Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Univar Inc (UNVR):企業の財務・戦略的SWOT分析
    Univar Inc (UNVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Angelique International Ltd:企業の戦略・SWOT・財務情報
    Angelique International Ltd - Strategy, SWOT and Corporate Finance Report Summary Angelique International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Vesteda Group:企業の戦略・SWOT・財務情報
    Vesteda Group - Strategy, SWOT and Corporate Finance Report Summary Vesteda Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Johnson Matthey Plc (JMAT):電力:M&Aディール及び事業提携情報
    Summary Johnson Matthey Plc (Johnson Matthey) is a specialty chemicals and sustainable technologies provider. It offers catalysts, fine chemicals, specialty chemical products and related technologies for various chemical processes and applications. It also undertakes the marketing, distribution, fab …
  • China Everbright Limited (165):企業の財務・戦略的SWOT分析
    China Everbright Limited (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Select Medical Holdings Corp (SEM):企業の財務・戦略的SWOT分析
    Summary Select Medical Holdings Corp (SMHC) is a healthcare service provider that offers outpatient rehabilitation services. The center provides long-term acute care services such as cardiac services, infectious disease treatment, medically complex treatment, neuro or post-trauma, pulmonary or venti …
  • Stagecoach Group plc (SGC):企業の財務・戦略的SWOT分析
    Stagecoach Group plc (SGC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Lotus Pharmaceutical Co Ltd (1795):製薬・医療:M&Aディール及び事業提携情報
    Summary Lotus Pharmaceutical Co Ltd (Lotus Pharmaceutical), a subsidiary of Alvogen Inc is a pharmaceutical company that develops and sells pharmaceutical products. The company provides products that are used in the treatment of rheumatology, cancer, cardiology, dyslipidemia, hypertension, woman hea …
  • Mattel, Inc (MAT):企業の財務・戦略的SWOT分析
    Mattel, Inc (MAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Exide Technologies:企業の戦略的SWOT分析
    Exide Technologies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Apache Corp (APA):石油・ガス:M&Aディール及び事業提携情報
    Summary Apache Corp (Apache) is an independent upstream energy company, which carries out exploration, development and production of natural gas, crude oil and natural gas liquids (NGLs). It has onshore and offshore asset base consisting of operations in the Permian Basin, the Anadarko basin in west …
  • RaQualia Pharma Inc (4579):製薬・医療:M&Aディール及び事業提携情報
    Summary RaQualia Pharma Inc (RaQualia) is a drug development company that discovers and develops pharmaceutical compounds. The company offers products such as anidulafungin, ziprasidone, dalbavancin, 5-HT2B antagonist, motilin receptor agonist, potassium-competitive acid blockerand 5-HT4 partial ago …
  • Avacta Group Plc (AVCT)-製薬・医療分野:企業M&A・提携分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products which include optim and sensipod. It also develops UCB celltech, which is an analytical instrument. Avacta’s sensipod is …
  • National Power Corporation:企業の戦略的SWOT分析
    National Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Major Drilling Group International Inc (MDI):企業の財務・戦略的SWOT分析
    Major Drilling Group International Inc (MDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆